Recently, reports have increasingly explored the complex regulatory mechanisms of SHBG in endocrine functions and its role in metabolic syndromes, e.g., obesity, diabetes mellitus, and NAFLD, highlighting its potential as a diagnostic marker and therapeutic target (Simons et al., 2021). This evidence concerns the gene SHBG and metabolic dysfunction-associated steatotic liver disease.